BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32418670)

  • 1. Quantification of late gadolinium enhancement cardiovascular MRI in patients with coronary artery chronic total occlusion.
    Zhang LJ; Dong W; Li JN; Mi HZ; Jiao J; Dou RY; An J; Liu JL; He Y; Song XT
    Clin Radiol; 2020 Aug; 75(8):643.e19-643.e26. PubMed ID: 32418670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.
    Harrigan CJ; Peters DC; Gibson CM; Maron BJ; Manning WJ; Maron MS; Appelbaum E
    Radiology; 2011 Jan; 258(1):128-33. PubMed ID: 21045187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy.
    Mikami Y; Kolman L; Joncas SX; Stirrat J; Scholl D; Rajchl M; Lydell CP; Weeks SG; Howarth AG; White JA
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):85. PubMed ID: 25315701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis.
    Gräni C; Eichhorn C; Bière L; Kaneko K; Murthy VL; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
    J Cardiovasc Magn Reson; 2019 Feb; 21(1):14. PubMed ID: 30813942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Yuki H; Utsunomiya D; Shiraishi S; Takashio S; Sakamoto F; Tsuda N; Oda S; Kidoh M; Nakaura T; Tsujita K; Yamashita Y
    Heart Vessels; 2018 Jun; 33(6):623-629. PubMed ID: 29230571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auto-threshold quantification of late gadolinium enhancement in patients with acute heart disease.
    Vermes E; Childs H; Carbone I; Barckow P; Friedrich MG
    J Magn Reson Imaging; 2013 Feb; 37(2):382-90. PubMed ID: 23011840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cine and late gadolinium enhancement MRI registration and automated myocardial infarct heterogeneity quantification.
    Guo F; Krahn PRP; Escartin T; Roifman I; Wright G
    Magn Reson Med; 2021 May; 85(5):2842-2855. PubMed ID: 33226667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late gadolinium uptake demonstrated with magnetic resonance in patients where automated PERFIT analysis of myocardial SPECT suggests irreversible perfusion defect.
    Rosendahl L; Blomstrand P; Ohlsson JL; Björklund PG; Ahlander BM; Starck SA; Engvall JE
    BMC Med Imaging; 2008 Dec; 8():17. PubMed ID: 19077270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological validation of semi-automated myocardial scar quantification techniques for dark-blood late gadolinium enhancement magnetic resonance imaging.
    Nies HMJM; Gommers S; Bijvoet GP; Heckman LIB; Prinzen FW; Vogel G; Van De Heyning CM; Chiribiri A; Wildberger JE; Mihl C; Holtackers RJ
    Eur Heart J Cardiovasc Imaging; 2023 Feb; 24(3):364-372. PubMed ID: 35723673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular volume fraction in coronary chronic total occlusion patients.
    Chen YY; Zhang WG; Yang S; Yun H; Deng SM; Fu CX; Zeng MS; Jin H; Guo L
    Int J Cardiovasc Imaging; 2015 Aug; 31(6):1211-21. PubMed ID: 25985941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (99m)Tc-MIBI SPECT/18F-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy: assessment of cardiac function and myocardial injury.
    Wang L; Yan C; Zhao S; Fang W
    Clin Nucl Med; 2012 Dec; 37(12):1163-9. PubMed ID: 23154474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative T1 Mapping for Detecting Microvascular Obstruction in Reperfused Acute Myocardial Infarction: Comparison with Late Gadolinium Enhancement Imaging.
    Shin JM; Choi EY; Park CH; Han K; Kim TH
    Korean J Radiol; 2020 Aug; 21(8):978-986. PubMed ID: 32677382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine.
    Lenkey Z; Varga-Szemes A; Simor T; van der Geest RJ; Kirschner R; Toth L; Bodnar T; Brott BC; Elgavish A; Elgavish GA
    J Magn Reson Imaging; 2016 Apr; 43(4):911-20. PubMed ID: 26354594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Myocardial Extracellular Volume Fraction Measured with Magnetic Resonance Imaging in the Prediction of Left Ventricular Functional Outcome after Revascularization of Chronic Total Occlusion of Coronary Arteries.
    Chen Y; Zheng X; Jin H; Deng S; Ren D; Greiser A; Fu C; Gao H; Zeng M
    Korean J Radiol; 2019 Jan; 20(1):83-93. PubMed ID: 30627024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining microvascular obstruction and infarct size with steady-state free precession imaging cardiac MRI.
    Wuest W; Lell M; May M; Scharf M; Schlundt C; Achenbach S; Uder M; Schmid A
    PLoS One; 2015; 10(3):e0119788. PubMed ID: 25793609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Magnetic Resonance Analysis of Myocardial Scarring With Biomarker Release Following S-T Elevation Myocardial Infarction.
    Costello BT; Stub D; Hare J; Ellims AH; Wang X; Smith K; Bernard S; Nehme Z; Stephenson M; Bray JE; Cameron P; Barger B; Meredith IT; Kaye DM; Iles L; Taylor AJ;
    Heart Lung Circ; 2019 Mar; 28(3):397-405. PubMed ID: 29526416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Myocardial Viability and Risk Stratification in Coronary Chronic Total Occlusion: A Qualitative and Quantitative Stress Cardiac MRI Study.
    Jiang M; Chen Y; Su Y; Guo H; Zhou X; Luo M; Zeng M; Hu X
    J Magn Reson Imaging; 2024 Feb; 59(2):535-545. PubMed ID: 37191039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of functional recovery after percutaneous coronary revascularization for chronic total occlusion using late gadolinium enhanced magnetic resonance imaging.
    Nakachi T; Kato S; Kirigaya H; Iinuma N; Fukui K; Saito N; Iwasawa T; Kosuge M; Kimura K; Tamura K
    J Cardiol; 2017 Jun; 69(6):836-842. PubMed ID: 28256296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.